If a patient is noted to have multiple PIRADS-4 and PIRAD-5 lesions of the prostate on MRI, do you offer simultaneous integrated boost via FLAME?  

If so, how do you determine which of the lesions constitutes the "dominant" lesion to boost?

Alternatively, do you treat all noted lesions with SIB, or do you avoid SIB altogether in this case where a dominant intraprostatic lesion is not easily identifiable?  



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at RadiantCare
Outstanding response. My practice is similar, also...
Sign in or Register to read more